Huntingtin interacts with cystathionine β-synthase

Human Molecular Genetics

Volumn 7, Issue 3, 1998, Pages 371-378

  Boutell, Jonathan M ^a   Wood, Jonathan D ^a   Harper, Peter S ^a   Lesley Jones, A ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATHIONINE BETA SYNTHASE; GLUTAMINE; HUNTINGTIN;

ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DNA LIBRARY; ESCHERICHIA COLI; HOMOCYSTINURIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALS; BETA-GALACTOSIDASE; BINDING SITES; BRAIN; CLONING, MOLECULAR; CYSTATHIONINE BETA-SYNTHASE; GENE LIBRARY; HOMOCYSTINURIA; HUMANS; HUNTINGTON DISEASE; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PEPTIDE FRAGMENTS; RATS; RECOMBINANT FUSION PROTEINS; SACCHAROMYCES CEREVISIAE;

EID: 0031909798     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/7.3.371     Document Type: Article

References (59)

1. Harper,P.S. (1996) Huntington's Disease, 2nd Edn. WB Saunders, London, UK.
2. Macdonald,M.E., Ambrose,C.M., Duyao,M.P., Myers,R.H., Lin,C., Srinidhi,L., Barnes,G., Taylor,S.A., James,M., Groot,N., Macfarlane,H., Jenkins,B., Anderson,M.A., Wexler,N.S., Gusella,J.F., Bates,G.P., Baxendale,S., Hummerich,H., Kirby,S., North,M., Youngman,S., Mott,R., Zehetner,G., Sedlacek,Z., Poustka,A., Frischauf,A.M., Lehrach,H., Buckler,A.J., Church,D., Doucettestamm,L., Odonovan,M.C., Ribaramirez,L., Shah,M., Stanton,V.P., Strobel,S.A., Draths,K.M., Wales,J.L., Dervan,P., Housman,D.E., Altherr,M, Shiang,R., Thompson,L., Fielder,T., Wasmuth,J.J., Tagle,D., Valdes,J., Elmer,L., Allard,M., Castilla,L., Swaroop,M., Blanchard,K., Collins,F.S., Snell,R., Holloway,T., Gillespie,K., Datson,N., Shaw,D. and Harper,P.S. (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntingtons disease chromosomes. Cell. 72, 971-983.
3. Rubinsztein,D.C., Leggo,J., Coles,R., Almqvist,E., Biancalana,V., Cassiman,J.J., Chotai,K., Connarty,M., Craufurd,D., Curtis,A., Curtis,D., Davidson,M.J., Differ,A.M., Dode,C., Dodge,A., Frontali,M., Ranen,N.G., Stine,O.C., Sherr,M., Abbott,M.H., Franz,M.L., Graham,C.A., Harper,P.S., Hedreen,J.C., Jackson,A., Kaplan,J.C., Losekoot,M., Macmillan,J.C., Morrison,P., Trottier,Y., Novelletto,A., Simpson,S.A., Theilmann,J., Whittaker,J.L., Folstein,S.E., Ross,C.A. and Hayden,M.R. (1996) Phenolypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals hd cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am. J. Hum. Genet., 59, 16-22.
4. Macmillan,J.C., Snell,R.G., Tyler,A., Houlihan,G.D., Fenton,I., Cheadle,J.P., Lazarou,L.P. Shaw,D.J. and Harper,P.S. (1993) Molecular analysis and clinical correlations of the Huntingtons disease mutation. Lancet, 342, 954-958.
5. Duyao,M.P., Ambrose,C.M., Myers,R.H., Novelletto,A., Persichetti,E., Barnes,G., Srinidhi,J., Bird,E., Vonsattel,J.P., Macdonald,M.E. and Gusella,J.F. (1993) Trinucleotide repeat length instability and age-of-onset in Huntingtons disease. Am. J. Hum. Genet., 53, 1152.
6. Andrew,S.E., Goldberg,Y.P., Kremer,B., Telenius,H., Theilmann,J., Adam,S., Starr,E., Squitieri,F., Lin,B.Y., Kalchman,M.A., Graham,R.K. and Hayden,M.R. (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntingtons disease. Nature Genet., 4, 398-403.
7. Difiglia,M., Sapp,E., Chase,K., Schwarz,C., Meloni,A., Young,C., Martin,E., Vonsattel,J.P., Carraway,R., Reeves,S.A., Boyce,F.M. and Aronin,N. (1995) Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron. 14, 1075-1081.
8. Ross,C.A., Li,S.H., Young,W.S., Schilling,G., Li,X.J., Stine,O.C., Margolis,R.L., Wagster,M.V., Ranen,N.G., Hedreen,J.C. and Folstein,S.E. (1993) Expression of IT-15 and lack of reduction in Huntingtons disease (HD). Am. J. Hum. Genet., 53, 85.
9. Trottier,Y., Devys,D., Imbert,G., Saudou,F., An,I., Lutz,Y. Weber,C., Agid,Y., Hirsch,E.C. and Mandel,J.L. (1995) Cellular-localization of the Huntinglons disease protein and discrimination of the normal and mutated form. Nature Genet., 10, 104-110.
10. Kosinski,C.M., Cha,J.H., Young,A.B., Persichetti,F., Macdonald,M., Gusella,J.F., Penney,J.B. and Standaert,D.G. (1997) Huntingtin immunoreactivity in the rat neostriatum: differential accumulation in projection and interneurons. Exp. Neurol., 144 239-247.
11. Jou,Y.S. and Myers,R.M. (1995) Evidence from antibody studies that the CAG repeat in the Huntington disease gene is expressed in the protein. Hum. Mol. Genet., 4, 465-469.
12. Aronin,N., Chase,K., Young,C., Sapp,E., Schwarz,C., Matta,N., Kornreich,R., Landwehrmeyer,B., Bird,E., Beal,M.F., Vonsattel,J.P., Smith,T., Carraway,R., Boyce,F.M., Young,A.B., Penney,J.B. and Difiglia,M. (1995) CAG expansion affects the expression of mutant huntingtin in the Huntingtons disease brain. Neuron, 15, 1193-1201.
13. Hedreen,J.C. and Folstein,S.E. (1995) Early loss of neostriatal striosome neurons in Huntington's disease. J. Neuropathol. Exp. Neurol., 54, 105-120.
14. Macmillan,J.C. and Quarrell,O.W.J, (1996) The neurobiology of Huntington's disease. In Harper,P.S. (ed.). Huntington's Disease, 2nd Edn. WB Saunders, London. UK. pp. 317-357.
15. Davies,S.W., Turmaine,M., Cozens,B.A., DiFiglia,M., Sharp,A.H., Ross,C.A., Scherzinger,E., Wanker,E.E., Mangiarini,L. and Bates,G.P. (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell, 90, 537-548.
16. DiFiglia,M., Sapp,E., Chase,K.O., Davies,S.W., Bales,G.P., Vonsattel,J.P. and Aronin,N. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science, 277, 1990-1993.
17. Li,X.J., Li,S.H., Sharp,A.H., Nucifora,F.C., Schilling,G., Lanahan,A., Worley,P., Snyder,S.H. and Ross,C.A. (1995) A huntingtin in-associated protein enriched in brain with implications for pathology. Nature, 378, 398-402.
18. Li,X.J., Sharp,A.H., Li,S.H., Dawson,T.M., Snyder,S.H. and Ross,C.A. (1996) Huntingtin-associated protein (HAPI) - discrete neuronal localizations in the brain resemble those of neuronal nitric-oxide synthase. Proc. Natl. Acad. Sci. USA, 93, 4839-4844.
19. Burke,J.R., Enghild,J.J., Martin,M.E., Jou,Y.S., Myers,R.M., Roses,A.D., Vance,J.M. and Strittmatter,W.J. (1996) Huntington and DRPLA proteins selectively interact with the enzyme gapdh. Nature Med., 2, 347-350.
20. Bao,J., Sharp,A.H., Wagster,M.V., Becher,M., Schilling,G., Ross,C.A., Dawson,V.L. and Dawson,T.M. (1996) Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Proc. Natl. Acad. Sci. USA, 93, 5037-5042.
21. Koshy,B., Matilla,T., Burright,E.N., Merry,D.E., Fischbeck,K.H., Orr,H.T. and Zoghbi,H.Y. (1996) Spinocerebellar ataxia type-1 and spinobulbar muscular-atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. Hum. Mol. Genet., 5, 1311-1318.
22. Brennan,W.A., Bird,E.D. and Aprille,J.R. (1985) Regional mitochondrial respiratory activity in Huntington's disease brain. J. Neurochem., 44, 1948-1950.
23. Parker,W.D., Boyson,S.J., Luder,A.S. and Parks,J.K. (1990) Evidence for a defect in NADH:ubiquinone oxidoreductase (complex I) in Huntington's disease. Neurology, 40, 1231-1233.
24. Gu,M., Gash,M.T, Mann,V.M., Javoyagid,F., Cooper,J.M. and Schapira,A.H.V. (1996) Mitochondrial detect in Huntingtons disease on caudate-nucleus. Ann. Neurol., 39, 385-389.
25. Koroshetz,W.J., Jenkins,B.G., Rosen,B.R. and Beal,M.F. (1997) Energy metabolism detects in Huntington's disease and effects of coenzyme Q(10). Ann. Neurol., 41, 160-165.
26. Kalchman,M.A., Graham,R.K., Xia,G., Koide,H.B., Hodgson,J.G., Graham,K.C, Goldberg,Y.P., Gietz,R.D., Pickart,C.M. and Hayden,M.R. (1996) Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme, J. Biol. Chem., 271, 19385-19394.
27. Wanker,E.E., Rovira,C., Scherzinger,E., Hasenbank,R., Walter,S., Tait,D., Colicelli,J. and Lehrach,H. (1997) HIP-1: a huntingtin interacting protein isolated by the yeast two-hybrid system. Hum. Mol. Genet., 6, 487-495.
28. Kalchman,M.A., Koide,H.B., Mccutcheon,K., Graham,R.K., Nichol,K., Nishiyama,K., Kazemiesfarjani,P., Lynn,F.C., Wellington,C., Metzler,M., Goldberg,Y.P., Kanazawa,I. Gietz,R.D. and Hayden,M.R. (1997) HIP1, a human homologue of S. cerevisiae Sla2p. interacts with membrane-associated huntingtin in the brain. Nature Genet., 16, 44-53.
29. Gutekunst,C.A., Levey,A.I., Heilman,C.J., Whaley,W.L., Yi,H., Nash,N.R., Rees,H.D., Madden,J.J. and Hersch,S.M. (1995) Identification and localization of huntingtin in brain and human lymphoblastoid cell-lines with anti-fusion protein antibodies. Proc. Natl. Acad Sci. USA, 92, 8710-8714.
30. Wood,J.D., Macmillan,J.C., Harper,P.S., Lowenstein,P.R. and Jones,A.L. (1996) Partial characterization of murine huntingtin and apparent variations in the subcellular-localization of huntingtin in human, mouse and rat-brain. Hum. Mol. Genet., 5, 481-187.
31. Beal,M.F., Ferrante,R.J., Swartz,K.J. and Kowall,N.W. (1991) Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J. Neurosci., 11, 1649-1659.
32. Difiglia,M. (1990) Excitotoxic injury in the neostriatum: a model for Huntington's disease. Trends Neurosci., 13, 286-289.
33. Beal,M.F., Hyman,B.T. and Koroshetz,W. (1993) Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases. Trends Neurosci., 16, 125-131.
34. Beal,M.F, Brouillet,E., Jenkins,B.G., Ferrante,R.J., Kowall,N.W., Miller,J.M., Storey,E., Srivastava,R., Rosen,B.R. and Hyman,B.T. (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosi., 13, 4181-4192.
35. Beal,M.F. (1994) Neurochemistry and toxin models in Huntingtons disease. Curr. Opin. Neurol., 7, 542-547.
36. Mangiarini,L., Sathasivam,K., Seller,M., Cozens,B., Harper,A., Hetherington,C., Lawton,M., Trottier,Y., Lehrach,H., Davies,S.W. and Bates,G.P. (1996) Exon-1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 87, 493-506.
37. Choi,D.W. (1988) Glutamate neurotoxicily and diseases of the nervous system. Neuron. 1, 623-634.
38. Ankarcrona,M., Dypbukt,J.M., Bonfoco,E., Zhivotovsky,B., Orrenius,S., Lipton,S.A. and Nicotera,P. (1995) Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function, Neuron, 15, 961-973.
39. Fields,S. and Song,O.K. (1989) A novel genetic system to detect protein-protein interactions. Nature, 340, 245-246.
40. Kraus,J.P., Le,K., Swaroop,M., Ohura,T., Tahara,T., Rosenberg,L.E., Roper,M.D. and Kozich,V. (1993) Human cystathionine β-synthase cDNA - sequence, alternative splicing and expression in cultured-cells. Hum. Mol. Genet., 2, 1633-1638.
41. Mudd,S.H., Finkelstein,J.D., Irreverre,F. and Laster,L. (1964) Homocystinuria: an enzymatic defect. Science. 143, 1443.
42. Kraus,J.P (1990) Molecular analysis of cystathionine β-synthase - a gene on chromosome 21. Prog. Clin. Biol. Res., 360, 201.
43. Mudd,S.H., Levy,H.L. and Skovby,F. (1995) Disorders of transsulfuration. In Seriver,C.R., Beaudet,A.L., Sly,W.S. and Valle,D. (eds). The Metabolic and Molecular Bases of Inherited Disease. 7th Edn. McGraw-Hill, New York. pp. 1279-1327.
44. Refsum,H., Helland,S. and Ueland,P.M. (1985) Radioenzymic determination of homocysteine in plasma and urine, Clin. Chem., 31, 624.
45. Perry,T.L. (1981) Mild elevations of plasma omithine in homocystinuria. Clin. Chim. Acta, 117, 97.
46. Dudman,N.P.B. and Wilcken,D.E.L. (1983) Increased plasma copper in patients with homocystinuria due to cystathionine β-synthase deficiency. Clin. Chim. Acta, 127, 105.
47. Barber,G.W. and Spaeth,G.L. (1967) Pyridoxine therapy in homocystinuria. Lancet, 1, 337.
48. Mudd,S.H., Skovby,F., Levy,H.L., Pettigrew,K.D., Wilcken,B., Pyeritz,R.E., Andria,G., Boers,G.H.J., Bromberg,I.L., Cerone,R., Fowler,B., Grobe,H., Schmidt,H. and Schweitzer,L. (1985) The natural history of homocystinuria due to cystathionine β-synthase deficiency, Am. J. Hum. Genet., 31, 1-31.
49. Abbott,M.H., Folstein,S.E., Abbey,H. and Pyeritz,R.E. (1987) Psychiatric manifestations of homocystinuria due to cystathionine β-synthase deficiency : prevalence, natural history, and relationship to neurologic impairment and vitamin B6-responsiveness. Am. J. Med. Genet., 26, 959-969.
50. Schwarz,S. and Zhou,G.Z. (1991) N-Methyl-D-aspartate receptors and CNS symptoms of homocystinuria. Lancet, 337, 1226-1227.
51. 3H]MK-801 binding to the phencyclidine recognition site and thus is an agonist for the N-methyl-D-aspartate operated cation channel. Neuroscience, 37, 193-200.
52. Ohmori,S., Kodama,H., Ikegami,T., Mizuhara,S., Oura,T., Isshiki,G. and Uemera,I. (1972) Unusual sulfur-containing amino acids in the urine of homocystinuric patients: III. Homocysteic acid, homocysteine sulfinic acid, S-(carboxymethylthio)homocysteine, and S-(3-hydroxy-3-carboxy-n-propyl) homocysteine. Physiol. Chem. Phys., 4, 286.
53. Skovby,F., Kraus,J.P. and Rosenberg,L.E. (1984) Biosynthesis and proteolytic activation of cystathionine β-synthase in rat liver. J. Biol. Chem., 259, 588.
54. Paulson,H.L., Perez,M.K., Trottier,Y., Trojanowski,J.Q., Subramony,S.H., Das,S.S., Vig,P., Mandel,J.-L., Fischbeck,K.H. and Pittman,R.N. (1997) Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron, 19, 333-344.
55. Boers,G.H.J., Smals,A.G.H. and Trijbels,F.J.M. (1985) Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. New Engl. J. Med., 313, 709-715.
56. Nagafuchi,S., Yanagisawa,H., Ohsaki,E., Shirayama,T., Tadokoro,K., Inoue,T. and Yamada,M. (1994) Structure and expression of the gene responsible for the triplet repeat disorder, dentatorubral and pallidoluysian atrophy (DRPLA). Nature Genet., 8, 177-182.
57. Schiestl,R.H. and Gietz,R.D. (1989) High efficiency transformation of intact cells using single stranded nucleic acids as a carrier. Curr. Genet., 16, 339-346.
58. Hoffman,C.S. and Winston,F. (1987) A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of E. coli, Gene, 57, 267-272.
59. Peterson,G.L. (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem., 83, 346-356.